AGA Medical Holdings Inc., a Plymouth, Minn.-based maker of medical devices the treatment of structural heart defects and vascular diseases, has set its IPO terms to 13.75 million common shares being offered at between $19 and $21 per share. It would have an initial market cap of approximately $1 billion, were it to price at the high end of its range. AGA plans to trade on the Nasdaq under ticker symbol AGAM, with BoA Merrill Lynch serving as lead underwriter.
Welsh Carson Anderson & Stowe acquired a majority stake AGA Medical via a 2005 equity recap. www.amplatzer.com